NDC properties for "0.8 ML Amjevita 50 MG/ML Auto-Injector" (RxCUI 2627722)
About this data
The tables show NDC propoerties for 0.8 ML Amjevita 50 MG/ML Auto-Injector with the RxCUI 2627722
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 0.8 ML Amjevita 50 MG/ML Auto-Injector (RxCUI 2627722)
| BLA | BLA761024 |
|---|---|
| MMSL_CODE | BD32553 |
| RxCUI | 2627722 |
| SPL_SET_ID | 9c44bd5b-4464-40a4-8933-8680950f00f2 |
| SPL_SET_ID | b7178e36-6787-45ab-8fee-be59bc6a4aa4 |
| Prescribable Synonym | AMJEVITA 40 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML Amjevita 50 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-atto 50 MG/ML Auto-Injector [Amjevita] |
| RxNorm Synonym | 0.8 ML Amjevita 50 MG/ML Auto-Injector |
| RxNorm Synonym | Amjevita 40 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2627722) |
NDC Properties
NDC Item 55513040001
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-01 |
| NDC Item | 55513040001 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040002
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-02 |
| NDC Item | 55513040002 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040091
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-91 |
| NDC Item | 55513040091 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 72511040001
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-01 |
| NDC Item | 72511040001 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 72511040002
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-02 |
| NDC Item | 72511040002 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 55513040001
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-01 |
| NDC Item | 55513040001 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040002
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-02 |
| NDC Item | 55513040002 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040091
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-91 |
| NDC Item | 55513040091 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 72511040001
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-01 |
| NDC Item | 72511040001 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 72511040002
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-02 |
| NDC Item | 72511040002 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 55513040001
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-01 |
| NDC Item | 55513040001 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040002
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-02 |
| NDC Item | 55513040002 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040091
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-91 |
| NDC Item | 55513040091 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 72511040001
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-01 |
| NDC Item | 72511040001 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 72511040002
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-02 |
| NDC Item | 72511040002 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 55513040001
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-01 |
| NDC Item | 55513040001 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040002
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-02 |
| NDC Item | 55513040002 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040091
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-91 |
| NDC Item | 55513040091 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 72511040001
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-01 |
| NDC Item | 72511040001 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 72511040002
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-02 |
| NDC Item | 72511040002 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 55513040001
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-01 |
| NDC Item | 55513040001 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040002
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-02 |
| NDC Item | 55513040002 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 55513040091
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-91 |
| NDC Item | 55513040091 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-400 |
NDC Item 72511040001
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-01 |
| NDC Item | 72511040001 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |
NDC Item 72511040002
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-02 |
| NDC Item | 72511040002 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-400 |